| 1 | [SID17505306] | Active | Potency | 0.5012 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.5012 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 2 | [SID17505306] | Active | Potency | 0.5858 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.5858 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID17505306] | Active | Potency | 0.7079 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 4 | [SID17505306] | Active | Potency | 0.7308 | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation [AID624305, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation | | AID | 624305 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 5 | [SID17505306] | Active | Potency | 0.7308 | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation [AID624305, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation | | AID | 624305 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 6 | [SID17505306] | Active | Potency | 0.7308 | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation [AID624305, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation | | AID | 624305 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 7 | [SID17505306] | Active | Potency | 0.7308 | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation [AID624305, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter: Hit Validation | | AID | 624305 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 8 | [SID17505306] | Active | Potency | 0.8492 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 0.8492 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 9 | [SID17505306] | Active | EC50 | 2.155 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | EC50 | 2.155 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID17505306] | Active | Potency | 3.1623 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 11 | [SID17505306] | Active | Potency | 3.1623 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 12 | [SID17505306] | Active | Potency | 5.1735 | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 13 | [SID17505306] | Active | EC50 | 7.892 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | EC50 | 7.892 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID17505306] | Active | EC50 | 9.714 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | EC50 | 9.714 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 15 | [SID17505306] | Active | Potency | 10 | Counterscreen for Luciferase (Kinase-Glo TM) Inhibition [AID1379, Type: confirmatory] | luciferase [Photuris pennsylvanica] [gi:1669525] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Counterscreen for Luciferase (Kinase-Glo TM) Inhibition | | AID | 1379 | | BioAssay type | confirmatory | | Target | luciferase [Photuris pennsylvanica] [gi:1669525] | | PubMed | | | Data Table |  |
|
| 16 | [SID17505306] | Active | Potency | 12.5893 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 17 | [SID17505306] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition [AID2785, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition | | AID | 2785 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 18 | [SID17505306] | Active | Potency | 18.3564 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID17505306] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID17505306] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID17505306] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID17505306] | Active | Potency | 19.9054 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 19.9054 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 23 | [SID17505306] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID17505306] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 25 | [SID17505306] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 26 | [SID17505306] | Active | Potency | 25.1189 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 27 | [SID17505306] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity [AID2786, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity | | AID | 2786 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID17505306] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 29 | [SID17505306] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 30 | [SID17505306] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 31 | [SID17505306] | Active | | | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID652136, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 652136 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17505306] | Active | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID17505306] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID17505306] | Active | | | Counter Screen for Luciferase-based Primary Inhibition Assays [AID1006, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Counter Screen for Luciferase-based Primary Inhibition Assays | | AID | 1006 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID17505306] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID17505306] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 37 | [SID17505306] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 38 | [SID17505306] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 39 | [SID17505306] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 40 | [SID17505306] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 41 | [SID17505306] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 42 | [SID17505306] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 43 | [SID17505306] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 44 | [SID17505306] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 45 | [SID17505306] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 46 | [SID17505306] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 47 | [SID17505306] | Active | | | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652134, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652134 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 48 | [SID17505306] | Active | | | Confirmation cell-based high throughput screening assay to measure STAT1 activation [AID1262, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Confirmation cell-based high throughput screening assay to measure STAT1 activation | | AID | 1262 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 49 | [SID17505306] | Active | | | Confirmation cell-based high throughput screening assay to measure STAT1 activation [AID1262, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Confirmation cell-based high throughput screening assay to measure STAT1 activation | | AID | 1262 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 50 | [SID17505306] | Active | | | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells [AID1273, Type: screening] | proinsulin [Homo sapiens] [gi:59036749] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17505306 | | CID | 9613210 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells | | AID | 1273 | | BioAssay type | screening | | Target | proinsulin [Homo sapiens] [gi:59036749] | | PubMed | | | Data Table |  |
|